Kamran Khan




Dr. Kamran Khan is an infectious disease physician with training in public health and preventive medicine based at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. He is a Professor of Medicine in the Division of Infectious Diseases and the Dalla Lana School Of Public Health at the University of Toronto. His research interests focus on the globalization of emerging and reemerging infectious diseases. He is also the founder of a social enterprise called BlueDot that develops innovative digital solutions to help governments, the private sector, and healthcare organizations build resilience to current and future global epidemic threats.

Recent Publications

  1. Harish, V, Samson, TG, Diemert, L, Tuite, A, Mamdani, M, Khan, K et al.. Governing partnerships with technology companies as part of the COVID-19 response in Canada: A qualitative case study. PLOS Digit Health. 2022;1 (12):e0000164. doi: 10.1371/journal.pdig.0000164. PubMed PMID:36812643 PubMed Central PMC9931354.
  2. Olawoye, IB, Oluniyi, PE, Oguzie, JU, Uwanibe, JN, Kayode, TA, Olumade, TJ et al.. Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria. Nat Commun. 2023;14 (1):811. doi: 10.1038/s41467-023-36449-5. PubMed PMID:36781860 PubMed Central PMC9924892.
  3. Huber, C, Watts, A, Thomas-Bachli, A, McIntyre, E, Tuite, A, Khan, K et al.. Using spatial and population mobility models to inform outbreak response approaches in the Ebola affected area, Democratic Republic of the Congo, 2018-2020. Spat Spatiotemporal Epidemiol. 2023;44 :100558. doi: 10.1016/j.sste.2022.100558. PubMed PMID:36707191 .
  4. Marwah, A, Ogoina, D, Au, NH, Gibb, NP, Portillo, MT, Thomas-Bachli, A et al.. Estimating the size of the monkeypox virus outbreak in Nigeria and implications for global control. J Travel Med. 2022;29 (8):. doi: 10.1093/jtm/taac149. PubMed PMID:36495194 .
  5. Tegally, H, Khan, K, Huber, C, de Oliveira, T, Kraemer, MUG. Shifts in global mobility dictate the synchrony of SARS-CoV-2 epidemic waves. J Travel Med. 2022;29 (8):. doi: 10.1093/jtm/taac134. PubMed PMID:36367200 PubMed Central PMC9793401.
  6. Parker, E, Anderson, C, Zeller, M, Tibi, A, Havens, JL, Laroche, G et al.. Regional connectivity drove bidirectional transmission of SARS-CoV-2 in the Middle East during travel restrictions. Nat Commun. 2022;13 (1):4784. doi: 10.1038/s41467-022-32536-1. PubMed PMID:35970983 PubMed Central PMC9376901.
  7. McKenzie, L, Shoukat, A, Wong, KO, Itahashi, K, Yasuda, E, Demarsh, A et al.. Inferring the true number of SARS-CoV-2 infections in Japan. J Infect Chemother. 2022;28 (11):1519-1522. doi: 10.1016/j.jiac.2022.08.002. PubMed PMID:35961504 PubMed Central PMC9359925.
  8. McCrone, JT, Hill, V, Bajaj, S, Pena, RE, Lambert, BC, Inward, R et al.. Context-specific emergence and growth of the SARS-CoV-2 Delta variant. Nature. 2022;610 (7930):154-160. doi: 10.1038/s41586-022-05200-3. PubMed PMID:35952712 PubMed Central PMC9534748.
  9. Au, NH, Portillo, MT, Marwah, A, Thomas-Bachli, A, Demarsh, PA, Khan, K et al.. Potential for monkeypox exportation from West and Central Africa through global travel networks. J Travel Med. 2022;29 (6):. doi: 10.1093/jtm/taac072. PubMed PMID:35642580 .
  10. Au, NH, Thomas-Bachli, A, Forsyth, J, Demarsh, PA, Huber, C, Bogoch, II et al.. Identifying importation points of the SARS-CoV-2 Omicron variant into the USA and potential locations of early domestic spread and impact. J Travel Med. 2022;29 (3):. doi: 10.1093/jtm/taac021. PubMed PMID:35234894 PubMed Central PMC9383474.
Search PubMed

Affiliations & Other Activities

  • Staff Physician, Department of Medicine, Division of Infectious Diseases, St. Michael’s Hospital
  • Professor, Department of Medicine, Division of Infectious Diseases, Dalla Lana School Of Public Health, University of Toronto